FDA Raises Big Safety Concerns With Johnson & Johnson's Arthritis Drug Sirukumab

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-johnson-johnson.jpg" NAME"FDA Raises Big Safety Concerns With Johnson & Johnson's Arthritis Drug Sirukumab" ALT"FDA Raises Big Safety Concerns With Johnson & Johnson's Arthritis Drug Sirukumab"July 31, 2017(Last Updated: July…

Continue ReadingFDA Raises Big Safety Concerns With Johnson & Johnson's Arthritis Drug Sirukumab

Bristol-Myers Squibb, Clovis Oncology Ink Pact to Marry Their PD-1/PARP Drugs in Phase II and III

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x600-deal.jpg" NAME"Bristol-Myers, Clovis Ink Pact to Marry Their PD-1/PARP Drugs in Phase II and III" ALT"Bristol-Myers, Clovis Ink Pact to Marry Their PD-1/PARP Drugs in Phase II and III"July…

Continue ReadingBristol-Myers Squibb, Clovis Oncology Ink Pact to Marry Their PD-1/PARP Drugs in Phase II and III

Illumina Accelerator in the Bay Area Makes Room for 5 New Biotech Startups

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-illumina.jpg" NAME"Illumina Accelerator in the Bay Area Makes Room for 5 New Biotech Startups" ALT"Illumina Accelerator in the Bay Area Makes Room for 5 New Biotech Startups"July 28, 2017By…

Continue ReadingIllumina Accelerator in the Bay Area Makes Room for 5 New Biotech Startups

Some GlaxoSmithKline Critics Would Prefer Broke Up the Company

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x400-glaxosmithkline.jpg" NAME"Some GlaxoSmithKline Critics Would Prefer Walmsley Broke Up the Company" ALT"Some GlaxoSmithKline Critics Would Prefer Walmsley Broke Up the Company"July 28, 2017By Mark Terry, BioSpace.com Breaking... Source: BioSpace

Continue ReadingSome GlaxoSmithKline Critics Would Prefer Broke Up the Company